Robotic surgical systems market in China to grow at 12% CAGR through 2036, forecasts GlobalData

The robotic surgical systems market in China is projected to experience significant growth, with a forecasted compound annual growth rate (CAGR) of approximately 12 per cent through 2036. This growth is mainly fueled by innovations in artificial intelligence (AI)-powered robotic assistance and the rising elderly population leading to an increase in need for surgical interventions, reveals GlobalData.

GlobalData’s report, “Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” shows that China accounted for around 30 per cent of the Asia-Pacific robotic surgical systems market in 2024, driven by the growing demand for advanced surgical technologies.

The recent regulatory approval of Shanghai-based Ronovo Surgical’s Carina robotic platform marks a significant milestone in China’s surgical robotics industry. Unlike conventional systems, Carina’s modular design offers flexibility in instrument selection and anatomical access, enabling tailored robotic-assisted surgeries across multiple specialties including urology, gynaecology, thoracic, and general surgery. This versatility enhances the accessibility and cost-effectiveness of robotic-assisted surgical procedures for hospitals.

Jyoti Sharma, Medical Devices Analyst at GlobalData, states, “This development underscores China’s commitment to foster in-house innovation in the field of surgical robotics, reducing operational expenses and reliance on imported devices. This reduction could allow a greater number of healthcare facilities to integrate robotic systems, thereby enhancing surgical precision.”

Beyond Ronovo Surgical, international companies have also expanded their footprint in China’s robotic surgery market. Johnson & Johnson’s Monarch robotic system received approval in 2023 for peripheral lung procedures, and Stereotaxis’ Genesis robot was cleared in 2024. These authorisations underscore the growing accessibility of various robotic-assisted technologies in China, offering hospitals additional options to enhance surgical results.

Sharma adds, “With the ongoing investment and an increasing number of regulatory approvals, the Chinese robotic surgical systems market is well-positioned for sustained growth. As increasing number of hospitals integrate these advanced systems, better patient outcomes and more favourable recovery experiences are expected. This progress will further solidify China’s role as a significant contributor to the dynamic field of robotic-assisted surgery.”